Clear Flow

IRVINE, Calif., September 02, 2025--ClearFlow has been selected to exhibit PleuraFlow Active Clearance Technology (ACT), an FDA-cleared chest drainage system used during and after cardiothoracic surgery which features a proprietary active clearance mechan

/PRNewswire/ -- ClearFlow Group is excited to unveil DualPool, a revolutionary self-dosing/self-limiting, two-stage pool clarifier designed to simplify and...

In the realm of cardiac surgery, advancements aren't solely about the procedures performed within the operating room. They also extend to the meticulous care and management post-surgery, crucial for ensuring optimal patient outcomes. One groundbreaking su

Improving outcomes and reducing hospital costs is a continual effort in modern healthcare. For heart surgery patients, a good place to start is by focusing on something that is common to nearly all recovering patients. All cardiac surgery patients have so

ClearFlow is dedicated to protecting quality of life by advancing healing with sustainable medical technology. During these unprecedented times with the developing coronavirus (COVID-19) situation, our core values continue to drive our decisions as we pri

All patients who have surgery have some degree of bleeding in the mediastinum in the immediate postoperative period, called Shed Mediastinal Blood (SMB). Usually this is a microvascular oozing rather than dramatic surgical bleeding. SMB must be cleared by

The Journal of Thoracic and Cardiovascular Surgery published a recent manuscript entitled "Systematic review and meta-analysis of randomized controlled trials assessing safety and efficacy of posterior pericardial drainage in patients undergoing heart sur